Bond & Steele Clinic Pa D/B/A Bond Clinic Pa

Summary Statement of Deficiencies D0000 An announced CLIA recertification survey was conducted at AdventHealth Bond Clinic on 1/20/2026 to 1/26/2026. The laboratory was surveyed under 42 CFR Part 493 CLIA requirements. Standard deficiencies cited are as follows: D2087 ROUTINE CHEMISTRY CFR(s): 493.841(a) (a) Failure to attain a score of at least 80 percent of acceptable responses for each analyte in each testing event is unsatisfactory analyte performance for the testing event. This STANDARD is not met as evidenced by: Based on record review and staff interview, the lab failed to achieve satisfactory performance for the analyte urine microalbumin for testing event (TE) 1 of two TEs (1 & 2) reviewed for 2025. Findings included: 1. The laboratory participated in proficiency with the American Proficiency Institute. The proficiency testing for urine micro was reviewed. There were two test events in 2025. The Performance Summary for the 2nd Chemistry - Miscellaneous TE, with a date of 11/12/2025 was reviewed. The score was 0% (unsatisfactory analyte performance). 2. The General Supervisor confirmed the above during an interview on 01/20/2026 at 1:50 p.m. D2094 ROUTINE CHEMISTRY CFR(s): 493.841(e) (e)(1) For any unsatisfactory analyte or test performance or testing event for reasons other than a failure to participate, the laboratory must undertake appropriate training and employ the technical assistance necessary to correct problems associated with a proficiency testing failure. (2) For any unacceptable analyte or testing event score, remedial action must be taken and documented, and the documentation must be maintained by the laboratory for two years from the date of participation in the Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 6 -- proficiency testing event. This STANDARD is not met as evidenced by: Based on record review and staff interview, the lab failed to take appropriate remedial action for the unsatisfactory analyte performance for the analyte urine microalbumin for 1 of 1 test event (TE 1 of 2025) that required remedial action. Findings included: 1. See D2087. 2. The Performance Review and

Summary Statement of Deficiencies D0000 An announced CLIA recertification survey was conducted at Bond & Steele Clinic PA DBA Bond Clinic PA on 08/18/2021. The laboratory is not in compliance with 42 CFR Part 493, Requirements for Laboratories. The following is a description of the standard level deficiencies: D5445 CONTROL PROCEDURES CFR(s): 493.1256(d)(1)(2)(g) Unless CMS Approves a procedure, specified in Appendix C of the State Operations Manual (CMS Pub. 7), that provides equivalent quality testing, the laboratory must-- (d)(1) Perform control procedures as defined in this section unless otherwise specified in the additional specialty and subspecialty requirements at 493.1261 through 493.1278. (d)(2) For each test system, perform control procedures using the number and frequency specified by the manufacturer or established by the laboratory when they meet or exceed the requirements in paragraph (d)(3) of this section. (g) The laboratory must document all control procedures performed. This STANDARD is not met as evidenced by: Based on record review and interview the laboratory failed to have a completed IQCP (Individualized Quality Control Plan) to allow QC (Quality Control) to be ran weekly on the Beckman Coulter Microscan per the manufacturer's instructions instead of daily since 11/01/2019. Findings Included: Review of QC on the Beckman Coulter Microscan revealed that QC was ran weekly since being validated on 11/01/2019. Review of the procedure provided by Beckman Coulter (2015 Beckman Coulter, Inc.) stated "You can either develop an IQCP or perform daily QC as described in current CLIA regulations. It will no longer be acceptable for your laboratory to follow CLSI AST guidelines alone for converting from daily to weekly testing of QC strains." "The IQCP consists of three parts: a Risk Assessment, a Quality Control Plan, and a Quality Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- Assurance Plan." Interview on 08/18/2021 at 5:18 PM the Laboratory General Supervisor and Microbiology Technical Supervisor confirmed that there was no IQCP for the Microscan. -- 2 of 2 --